[go: up one dir, main page]

SV2008003139A - Profarmacos de penem - Google Patents

Profarmacos de penem

Info

Publication number
SV2008003139A
SV2008003139A SV2008003139A SV2008003139A SV2008003139A SV 2008003139 A SV2008003139 A SV 2008003139A SV 2008003139 A SV2008003139 A SV 2008003139A SV 2008003139 A SV2008003139 A SV 2008003139A SV 2008003139 A SV2008003139 A SV 2008003139A
Authority
SV
El Salvador
Prior art keywords
profarms
penem
profulars
biodisponibility
sulopenem
Prior art date
Application number
SV2008003139A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Anthony Marfat
Dale Gordon Mcleod
John Paul O'donnell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2008003139A publication Critical patent/SV2008003139A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROFÁRMACOS DE SULOPENEM CON BIODISPONIBILIDAD POR VÍA ORAL, POR EJEMPLO: (VER FORMULA); Y SUS SOLVATOS E HIDRATOS, SU PREPARACIÓN, SU FORMULACIÓN Y SU USO PARA TRATAR Y PREVENIR LA INFECCIÓN EN MAMÍFEROS TALES COMO SERES HUMANOS. ESTE RESUMEN NO LIMITA LA INVENCIÓN
SV2008003139A 2006-06-28 2008-12-23 Profarmacos de penem SV2008003139A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13

Publications (1)

Publication Number Publication Date
SV2008003139A true SV2008003139A (es) 2010-01-12

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008003139A SV2008003139A (es) 2006-06-28 2008-12-23 Profarmacos de penem

Country Status (28)

Country Link
US (2) US7795243B2 (es)
EP (1) EP2044085B1 (es)
JP (2) JP4397435B2 (es)
KR (1) KR101060448B1 (es)
AP (1) AP2008004705A0 (es)
AR (1) AR061646A1 (es)
AT (1) ATE493419T1 (es)
AU (1) AU2007263519B2 (es)
BR (1) BRPI0712740A2 (es)
CA (1) CA2655485C (es)
CL (1) CL2007001910A1 (es)
CR (1) CR10467A (es)
DE (1) DE602007011622D1 (es)
DK (1) DK2044085T3 (es)
EA (1) EA200870584A1 (es)
EC (1) ECSP088947A (es)
GT (1) GT200700050A (es)
IL (1) IL195383A0 (es)
MA (1) MA30568B1 (es)
MX (1) MX2009000116A (es)
NL (1) NL2000715C2 (es)
NO (1) NO20090392L (es)
PE (1) PE20080940A1 (es)
SV (1) SV2008003139A (es)
TN (1) TNSN08537A1 (es)
TW (1) TW200816999A (es)
UY (1) UY30439A1 (es)
WO (1) WO2008001212A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
CA2768877A1 (en) * 2009-08-10 2011-02-17 Bellus Health Inc. Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EA202192193A1 (ru) * 2019-02-13 2021-11-09 Итерум Терапьютикс Интернэшнл Лимитед Комбинации бета-лактамных соединений и пробенецида и их применения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
WO1988008845A1 (en) * 1987-05-11 1988-11-17 Pfizer Inc. Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) * 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
JP3148236B2 (ja) * 1990-08-20 2001-03-19 サントリー株式会社 ペネム化合物
ES2123512T3 (es) * 1990-08-20 1999-01-16 Suntory Ltd Compuestos de penem antibacterianos.
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
GT200700050A (es) 2008-02-01
US20080009474A1 (en) 2008-01-10
MA30568B1 (fr) 2009-07-01
TW200816999A (en) 2008-04-16
CA2655485A1 (en) 2008-01-03
AP2008004705A0 (en) 2008-12-31
ATE493419T1 (de) 2011-01-15
UY30439A1 (es) 2008-01-31
ECSP088947A (es) 2009-01-30
NL2000715C2 (nl) 2008-03-11
HK1134928A1 (en) 2010-05-20
US20090042853A1 (en) 2009-02-12
TNSN08537A1 (fr) 2010-04-14
NL2000715A1 (nl) 2008-01-02
WO2008001212A2 (en) 2008-01-03
MX2009000116A (es) 2009-01-23
JP2010013468A (ja) 2010-01-21
AU2007263519B2 (en) 2011-05-19
EA200870584A1 (ru) 2009-06-30
JP4397435B2 (ja) 2010-01-13
US7795244B2 (en) 2010-09-14
CR10467A (es) 2009-01-19
AR061646A1 (es) 2008-09-10
DE602007011622D1 (en) 2011-02-10
CA2655485C (en) 2011-08-02
EP2044085B1 (en) 2010-12-29
IL195383A0 (en) 2009-08-03
US7795243B2 (en) 2010-09-14
JP2009542616A (ja) 2009-12-03
EP2044085A2 (en) 2009-04-08
PE20080940A1 (es) 2008-07-09
NO20090392L (no) 2009-01-27
AU2007263519A1 (en) 2008-01-03
KR20090015147A (ko) 2009-02-11
DK2044085T3 (da) 2011-03-07
JP5152527B2 (ja) 2013-02-27
BRPI0712740A2 (pt) 2012-06-05
KR101060448B1 (ko) 2011-08-29
WO2008001212A3 (en) 2008-03-20
CL2007001910A1 (es) 2008-01-11

Similar Documents

Publication Publication Date Title
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BRPI0411528A (pt) uso de isomalte como prebiótico
MY145117A (en) Disposable diaper
SV2008003139A (es) Profarmacos de penem
EA201170832A1 (ru) Пуриновые соединения
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
CR20120158A (es) Compuestos de diòxido de iminotiadiazina como inhibidores de bace, composiciones y su uso.
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
IT1392903B1 (it) Composizione comprendente un'associazione di principi attivi per uso nel trattamento topico della calvizie
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MX2011012533A (es) Espiro-epoxidos como productos intermedios.
BR112015013675A2 (pt) composições compreendendo vortioxetina e donepezil
CL2013000400A1 (es) Conjugado de factor estimulante de colonia granulocito (g-csf) con polietilenglicol; composicion farmaceutica que lo contiene; y uso para la profilaxis o tratamiento de leucopenia.
UY32520A (es) Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
SG158091A1 (en) Imidazoazepinone compounds
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.

Legal Events

Date Code Title Description
FD Lapse